Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Wiedemuth

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The International Journal of Biochemistry & Cell Biology|February 9, 2018
UTX - moonlighting in the cytoplasm?Ralf Wiedemuth, Sebastian Thieme, Katrin Navratiel, et al.
Carcinogenesis|August 13, 2016
Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progenyRalf Wiedemuth, Barbara Klink, Mamoru Fujiwara, et al.
BMC Cancer|December 29, 2017
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cellsMarina Conde, Susanne Michen, Ralf Wiedemuth, et al.
Molecular Cancer|June 3, 2014
Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53Ralf Wiedemuth, Barbara Klink, Katrin Töpfer, et al.
Plos One|March 1, 2018
The Dox-pDC - A murine conditionally immortalized plasmacytoid dendritic cell line with native immune profileSebastian Thieme, Alexander Holzbaur, Ralf Wiedemuth, et al.
Frontiers in Immunology|May 3, 2021
Listening to the Whispers in Neuroimmune Crosstalk: A Comprehensive Workflow to Investigate Neurotrophin Receptor p75NTR Under Endogenous, Low Abundance ConditionsBenjamin W Dorschner, Ralf Wiedemuth, Ann-Christin Funke, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 4, 2014
Overcoming concealment effects of targeting moieties in the PEG corona: controlled permeable polymersomes decorated with folate-antennae for selective targeting of tumor cellsMohamed A Yassin, Dietmar Appelhans, Ralf Wiedemuth, et al.
BMC Biology|May 5, 2026
TRAM-LAG1-CLN8 domain-containing protein TMEM56 regulates cell migration by changing intracellular ceramide levelsBenjamin Dorschner, Ralf Wiedemuth, Cornelia Richter, et al.
Neuro-Oncology|July 27, 2011
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoSandy Hendruschk, Ralf Wiedemuth, Achim Aigner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2015
DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapyKatrin Töpfer, Marc Cartellieri, Susanne Michen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The International Journal of Biochemistry & Cell Biology|February 9, 2018
UTX - moonlighting in the cytoplasm?Ralf Wiedemuth, Sebastian Thieme, Katrin Navratiel, et al.
Carcinogenesis|August 13, 2016
Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progenyRalf Wiedemuth, Barbara Klink, Mamoru Fujiwara, et al.
BMC Cancer|December 29, 2017
Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cellsMarina Conde, Susanne Michen, Ralf Wiedemuth, et al.
Molecular Cancer|June 3, 2014
Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53Ralf Wiedemuth, Barbara Klink, Katrin Töpfer, et al.
Plos One|March 1, 2018
The Dox-pDC - A murine conditionally immortalized plasmacytoid dendritic cell line with native immune profileSebastian Thieme, Alexander Holzbaur, Ralf Wiedemuth, et al.
Frontiers in Immunology|May 3, 2021
Listening to the Whispers in Neuroimmune Crosstalk: A Comprehensive Workflow to Investigate Neurotrophin Receptor p75NTR Under Endogenous, Low Abundance ConditionsBenjamin W Dorschner, Ralf Wiedemuth, Ann-Christin Funke, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 4, 2014
Overcoming concealment effects of targeting moieties in the PEG corona: controlled permeable polymersomes decorated with folate-antennae for selective targeting of tumor cellsMohamed A Yassin, Dietmar Appelhans, Ralf Wiedemuth, et al.
BMC Biology|May 5, 2026
TRAM-LAG1-CLN8 domain-containing protein TMEM56 regulates cell migration by changing intracellular ceramide levelsBenjamin Dorschner, Ralf Wiedemuth, Cornelia Richter, et al.
Neuro-Oncology|July 27, 2011
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoSandy Hendruschk, Ralf Wiedemuth, Achim Aigner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2015
DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapyKatrin Töpfer, Marc Cartellieri, Susanne Michen, et al.
Pageof 2